Cefaclor (Ceclor)

12/01/1988 - "Such bacteriological activity of SBTPC was well reflected in its clinical efficacy; the drug was effective in patients with infections caused by organisms moderately or highly resistant to ABPC or cefaclor."
01/01/1991 - "In contrast, cefaclor proved more effective in experimental staphylococcus infections. "
01/01/1979 - "Clinical experience and laboratory tests in 52 patients (14 to 77 years of age) who had moderate to severe ear, nose, and throat infections were evaluated in this study of cefaclor, a new cephalosporin antibiotic, The drug proved to be effective in the treatment of these infections, and the incidence of side effects was low. "
12/01/1994 - "In experimental intraperitoneal infections in mice, cefaclor was therapeutically effective against both mutants, showing 50% effective doses of less than 10 mg/kg/dose. "
08/01/1983 - "Cefaclor appeared to be equally effective in the treatment of both ACB-positive and ACB-negative infections. "

12/01/2004 - "Cefaclor therapy is very effective for treating children aged 2-6 years affected by acute otitis media, with no significant difference related to treatment duration. "
07/01/2001 - "The aim of this study was to evaluate the efficacy of cefaclor in the prophylaxis of recurrent acute otitis media (AOM) in human immunodeficiency virus (HIV)-infected children. "
12/01/2004 - "Clinical efficacy and tolerability of two different regimens of cefaclor were studied in 410 paediatric patients affected by non-recurrent acute otitis media (AOM). "
12/01/2004 - "[Clinical efficacy and tolerability of short course therapy with cefaclor compared with long-term therapy for treatment of acute otitis media in children]."
12/01/2003 - "In children with cefaclor SSLR, otitis media was the most common indication (59.4%), another 18.8% had viral illnesses. "

11/01/1981 - "The efficacy of single-dose (cefaclor, 2 g orally) and multidose (cefaclor, 250 mg orally three times a day for 10 days) antibiotic regimens in the therapy of acute uncomplicated urinary tract infections (UTI) in nonpregnant women were compared. "
11/01/1997 - "Our study showed that cefaclor was still active against most Enterobacteriaceae, such as Escherichia coli and Klebsiella species, the principle pathogens of urinary tract infection. "
07/01/1996 - "[Non-comparative open study of the efficacy and tolerance of cefaclor in the prevention of urinary tract infections in children]."
02/01/1994 - "[A double blind controlled study on S6472 capsules and granules in complicated urinary tract infection]."
11/01/1990 - "[Clinical study of S 6472 in urinary tract infection]."

01/01/1979 - "Cefaclor is useful in the management of acute lower respiratory tract infections by virtue of its excellent clinical efficacy and safety."
01/01/1985 - "influenzae and because of its good tolerance Cefaclor is very useful in treatment of respiratory tract infections in children."
01/01/1990 - "Cefaclor appears to be an appropriate antibiotic for the safe and effective treatment of respiratory tract infections caused by M. "
01/01/1990 - "A retrospective analysis of data from 18 clinical studies was performed to examine the effectiveness and safety of cefaclor in the treatment of upper and lower respiratory tract infections caused by Moraxella catarrhalis (previously called Branhamella catarrhalis). "
04/01/1984 - "[Clinical studies of cefaclor for respiratory tract infections]."

12/01/2005 - "Overall, evaluations were performed on 16 studies (Medline/PubMed, keywords "Cefaclor and tonsillo-pharyngitis) which proved eligible (Jadad score > or = 1); twelve out of 16 studies were multicentre ones, only one was a double-blind study. "
01/01/2003 - "Before his visit to our clinic, he had been diagnosed as pharyngitis and treated with cefaclor 750 mg daily for six days. "
01/01/1992 - "Two double-blind, double-dummy, randomized multicentre studies compared the safety and efficacy of 10-day regimens of cefaclor advanced formulation (cefaclor AF) (375 mg twice daily) with cefaclor (250 mg three times daily) in the treatment of proven group A beta-haemolytic streptococcal pharyngitis/tonsillitis. "
01/01/1992 - "Cefaclor AF (375 mg twice daily) is as effective and safe as cefaclor capsules (250 mg three times daily) in the treatment of streptococcal pharyngitis/tonsillitis."
01/01/1992 - "Cefaclor AF in the treatment of streptococcal pharyngitis/tonsillitis."